
Company valuation, historical trends, and peer comparisons.
According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.45B. This represents a change of 118.91% compared to the average of 664.40M of the last 4 quarters.
The mean historical Enterprise Value of Eton Pharmaceuticals, Inc. over the last ten years is 162.61M. The current 1.45B Enterprise Value has changed 794.44% with respect to the historical average. Over the past ten years (40 quarters), ETON's Enterprise Value was at its highest in in the June 2026 quarter at 1.00B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
162.61M
Median
100.43M
Minimum
12.54M
Maximum
460.09M
Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 859.73%
Maximum Annual Enterprise Value = 460.09M
Minimum Annual Increase = -86.93%
Minimum Annual Enterprise Value = 12.54M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 460.09M | 27.81% |
| 2024 | 359.98M | 273.66% |
| 2023 | 96.34M | 57.60% |
| 2022 | 61.13M | -39.13% |
| 2021 | 100.43M | -35.89% |
| 2020 | 156.66M | 30.15% |
| 2019 | 120.37M | 859.73% |
| 2018 | 12.54M | -86.93% |
The current Enterprise Value of Eton Pharmaceuticals, Inc. (ETON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
305.47M
5-year avg
215.59M
10-year avg
162.61M
Eton Pharmaceuticals, Inc.’s Enterprise Value is less than Ionis Pharmaceuticals, Inc. (8.92B), less than Ultragenyx Pharmaceutical Inc. (2.68B), less than Travere Therapeutics, Inc. (5.14B), greater than Pharming Group N.V. (815.15M), greater than Zevra Therapeutics, Inc. (455.95M), greater than Lexicon Pharmaceuticals, Inc. (659.09M), greater than Fennec Pharmaceuticals Inc. (328.36M), greater than Larimar Therapeutics, Inc. (158.47M), greater than DiaMedica Therapeutics Inc. (496.03M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 8.92B | $6.85B | |
| 2.68B | $1.61B | |
| 5.14B | $4.64B | |
| 815.15M | $897.05M | |
| 455.95M | $599.78M | |
| 659.09M | $640.74M | |
| 328.36M | $369.61M | |
| 158.47M | $246.20M | |
| 496.03M | $500.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Eton Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Eton Pharmaceuticals, Inc. (ETON)?
What is the 3-year average Enterprise Value for Eton Pharmaceuticals, Inc. (ETON)?
What is the 5-year average Enterprise Value for Eton Pharmaceuticals, Inc. (ETON)?
How does the current Enterprise Value for Eton Pharmaceuticals, Inc. (ETON) compare to its historical average?